MARAVAI LIFESCIENCES HOLDINGS, INC. Income Statement
MRVI / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
MARAVAI LIFESCIENCES HOLDINGS, INC. reported $186M in revenue and $131M in net loss for FY2025. Revenue has grown at a 4.4% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $185.7M | $259.2M | $288.9M | $883.0M | $799.2M | $284.1M | $143.1M |
| Cost of Revenue | $151.8M | $150.9M | $148.7M | $169.0M | $140.6M | $79.6M | $66.8M |
| Gross Profit | $34.0M | $108.3M | $140.2M | - | - | - | - |
| SG&A Expense | $145.1M | $161.8M | $151.4M | $129.3M | $100.1M | $94.2M | $48.4M |
| R&D Expense | $17.4M | $19.2M | $17.3M | $18.4M | $15.2M | $9.3M | $3.6M |
| Operating Income | -$215.3M | -$235.6M | -$31.6M | $574.2M | $554.6M | $119.9M | $24.0M |
| Interest Expense | - | - | $45.9M | $20.4M | $30.3M | $30.7M | $30.0M |
| Income Tax | -$4.2M | -$1.9M | $756.1M | $60.8M | $61.5M | $2.9M | -$652.0K |
| Net Income | -$130.8M | -$144.8M | -$119.0M | $220.2M | $182.0M | $89.0M | -$4.5M |
| EPS (Basic) | -$0.90 | $1.67 | $1.59 | $7.43 | -$0.03 | $7.43 | -$0.03 |
| EPS (Diluted) | -$0.90 | $1.67 | $1.56 | $2.36 | -$0.03 | $2.36 | -$0.03 |
| Shares Outstanding | 131.9M | 255.3M | 257.8M | 28.9M | 253.9M | 28.9M | 253.9M |
| Gross Margin | 18.3% | 41.8% | 48.5% | - | - | - | - |
| Operating Margin | -115.9% | -90.9% | -10.9% | 65.0% | 69.4% | 42.2% | 16.8% |
| Profit Margin | -70.4% | -55.9% | -41.2% | 24.9% | 22.8% | 31.3% | -3.1% |